ATE421510T1 - Kompetitive atp-kinasehemmer - Google Patents

Kompetitive atp-kinasehemmer

Info

Publication number
ATE421510T1
ATE421510T1 AT06739676T AT06739676T ATE421510T1 AT E421510 T1 ATE421510 T1 AT E421510T1 AT 06739676 T AT06739676 T AT 06739676T AT 06739676 T AT06739676 T AT 06739676T AT E421510 T1 ATE421510 T1 AT E421510T1
Authority
AT
Austria
Prior art keywords
formula
kinase inhibitors
compounds
useful
growth factor
Prior art date
Application number
AT06739676T
Other languages
English (en)
Inventor
Ashvinikumar V Gavai
Ping Chen
Yufen Zhao
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ATE421510T1 publication Critical patent/ATE421510T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
AT06739676T 2005-03-28 2006-03-27 Kompetitive atp-kinasehemmer ATE421510T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66582605P 2005-03-28 2005-03-28

Publications (1)

Publication Number Publication Date
ATE421510T1 true ATE421510T1 (de) 2009-02-15

Family

ID=36648660

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06739676T ATE421510T1 (de) 2005-03-28 2006-03-27 Kompetitive atp-kinasehemmer

Country Status (6)

Country Link
US (1) US7358256B2 (de)
EP (1) EP1863792B1 (de)
AT (1) ATE421510T1 (de)
DE (1) DE602006004976D1 (de)
ES (1) ES2319462T3 (de)
WO (1) WO2006104971A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2941948B1 (fr) * 2009-02-12 2013-04-05 Nova Decision Derives d'azaindoles en tant qu'inhibiteur des proteines kinases abl et src
AU2010279188A1 (en) * 2009-07-28 2012-02-23 Ube Industries, Ltd. Pyrrolo[2,3-d]pyrimidine derivative

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8910722D0 (en) 1989-05-10 1989-06-28 Smithkline Beckman Intercredit Compounds
AU661533B2 (en) 1992-01-20 1995-07-27 Astrazeneca Ab Quinazoline derivatives
GB9323290D0 (en) 1992-12-10 1994-01-05 Zeneca Ltd Quinazoline derivatives
GB9514265D0 (en) 1995-07-13 1995-09-13 Wellcome Found Hetrocyclic compounds
GB9613021D0 (en) * 1996-06-21 1996-08-28 Pharmacia Spa Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors
USPP10146P (en) 1996-07-31 1997-12-09 Caldwell; E. Bond Spathiphyllum plant `Bond B`
CA2239227C (en) * 1996-10-01 2007-10-30 Kenji Matsuno Nitrogen-containing heterocyclic compounds
ID29800A (id) 1999-02-27 2001-10-11 Boehringer Ingelheim Pharma Turunan-turunan 4-amino-kinazolin dan kinolin yang mempunyai efek inhibitor pada transduksi signal yang dimediasi oleh tirosin kinase
DE19911509A1 (de) 1999-03-15 2000-09-21 Boehringer Ingelheim Pharma Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
GB9922171D0 (en) * 1999-09-21 1999-11-17 Zeneca Ltd Chemical compounds
US7081454B2 (en) 2001-03-28 2006-07-25 Bristol-Myers Squibb Co. Tyrosine kinase inhibitors
TW200300350A (en) 2001-11-14 2003-06-01 Bristol Myers Squibb Co C-5 modified indazolylpyrrolotriazines
TW200505452A (en) * 2003-06-17 2005-02-16 Astrazeneca Ab Chemical compounds
MY145634A (en) 2003-12-29 2012-03-15 Bristol Myers Squibb Co Pyrrolotriazine compounds as kinase inhibitors
US7064203B2 (en) 2003-12-29 2006-06-20 Bristol Myers Squibb Company Di-substituted pyrrolotriazine compounds
TW200635927A (en) * 2004-12-22 2006-10-16 Bristol Myers Squibb Co Synthetic process
US20060132093A1 (en) 2004-12-22 2006-06-22 Nguyen Don J Battery pack leakage cut-off

Also Published As

Publication number Publication date
EP1863792B1 (de) 2009-01-21
WO2006104971A1 (en) 2006-10-05
ES2319462T3 (es) 2009-05-07
DE602006004976D1 (de) 2009-03-12
US20060217369A1 (en) 2006-09-28
EP1863792A1 (de) 2007-12-12
US7358256B2 (en) 2008-04-15

Similar Documents

Publication Publication Date Title
DE602005023732D1 (de) Pyrrolotriazinverbindungen
MY145634A (en) Pyrrolotriazine compounds as kinase inhibitors
TW200420565A (en) C-6 modified indazolylpyrrolotriazines
MXPA04004492A (es) Indazolilpirrolotriazinas c-5 modificadas.
EA200900152A1 (ru) Ингибиторы пирролотриазинкиназы
WO2006007378A3 (en) Pyrrolotriazine kinase inhibitors
MXPA05000715A (es) Inhibidores novedosos de cinasas.
WO2004001059A3 (en) Heterocyclic inhibitors of kinases
WO2008060907A3 (en) Pyrrolo-pyridine kinase inhibitors
MX2012002480A (es) Inhibidores de jak2 y su uso en el tratamiento de enfermedades mieloproliferativas y cancer.
EA201100580A1 (ru) Имидазопиридазинкарбонитрилы, используемые в качестве ингибиторов киназы
EA200901488A1 (ru) Замещенные имидазолопиридазины, как ингибиторы липидкиназы
SG132683A1 (en) Imidazopyrazine tyrosine kinase inhibitors
MY139689A (en) Imidazotriazines as protein kinase inhibitors
ATE381557T1 (de) Rho-kinase inhibitoren
NO20090581L (no) Hydroksylerte og metoksylerte syklopenta[D]pyrimidiner som AKT-proteinkinaseinhibitorer
EA200901442A1 (ru) Комбинированная терапия соединением, проявляющим активность ингибитора рецептора адф на тромбоцитах
ATE478856T1 (de) Spirobenzodioxole und deren verwendung als cb1- antagonisten
NO20063324L (no) 3-cyano-kinolinderivater med antiproliferativ aktivitet
WO2005065266A3 (en) Di-substituted pyrrolotriazine compounds
ATE421510T1 (de) Kompetitive atp-kinasehemmer
TW200635927A (en) Synthetic process
CY1115576T1 (el) Αναστολεις jακ2 και χρηση αυτων για τη θεραπεια μυελοπολλαπλασιαστικων ασθενειων και καρκινου
UA97235C2 (ru) Производные хиназолина и конденсированного пиримидина в качестве ингибитора erbb

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties